![]() |
Name |
2-Naphthalenemethanol
|
Molecular Formula | C11H10O | |
IUPAC Name* |
naphthalen-2-ylmethanol
|
|
SMILES |
C1=CC=C2C=C(C=CC2=C1)CO
|
|
InChI |
InChI=1S/C11H10O/c12-8-9-5-6-10-3-1-2-4-11(10)7-9/h1-7,12H,8H2
|
|
InChIKey |
MFGWMAAZYZSWMY-UHFFFAOYSA-N
|
|
Synonyms |
2-NAPHTHALENEMETHANOL; 1592-38-7; naphthalen-2-ylmethanol; 2-Naphthylmethanol; 2-Hydroxymethylnaphthalene; (2-Naphthyl)methanol; 2-Naphthalene methanol; Naphthalen-2-yl-methanol; (naphthalen-2-yl)methanol; beta-Naphthylcarbinol; CHEBI:27615; MFCD00004124; 2-naphthalenearbinol; 2-naphthylmethan-1-ol; 2-naphtylmethanol; Naphthalenemethanol; 2NA; (2-naphtyl)methanol; naphth-2-yl-methanol; NSC 408615; 2-Naphthylmethanol #; naphthalene-2-methanol; naphthalen-2-yl methanol; bmse000683; 2-(hydroxymethyl)napthalene; 2-(Hydroxymethyl)naphthalene; SCHEMBL94384; 2-Naphthalenemethanol, 98%; CHEMBL150445; F3395-0160; DTXSID70166607; ZINC968147; BCP27493; NSC408615; AKOS000249365; AC-5795; CS-W001953; FS-3194; NSC-408615; SY021110; AM20060936; FT-0608823; N0881; C02909; EN300-1263458; 592N387; J-510146; Q27103227
|
|
CAS | 1592-38-7 | |
PubChem CID | 74128 | |
ChEMBL ID | CHEMBL150445 |
Chemical Classification: |
|
|
---|
Molecular Weight: | 158.2 | ALogp: | 2.2 |
HBD: | 1 | HBA: | 1 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 20.2 | Aromatic Rings: | 2 |
Heavy Atoms: | 12 | QED Weighted: | 0.676 |
Caco-2 Permeability: | -4.276 | MDCK Permeability: | 0.00001860 |
Pgp-inhibitor: | 0.003 | Pgp-substrate: | 0.007 |
Human Intestinal Absorption (HIA): | 0.012 | 20% Bioavailability (F20%): | 0.96 |
30% Bioavailability (F30%): | 0.187 |
Blood-Brain-Barrier Penetration (BBB): | 0.897 | Plasma Protein Binding (PPB): | 90.14% |
Volume Distribution (VD): | 1.485 | Fu: | 11.11% |
CYP1A2-inhibitor: | 0.971 | CYP1A2-substrate: | 0.388 |
CYP2C19-inhibitor: | 0.683 | CYP2C19-substrate: | 0.161 |
CYP2C9-inhibitor: | 0.144 | CYP2C9-substrate: | 0.173 |
CYP2D6-inhibitor: | 0.395 | CYP2D6-substrate: | 0.838 |
CYP3A4-inhibitor: | 0.037 | CYP3A4-substrate: | 0.369 |
Clearance (CL): | 10.848 | Half-life (T1/2): | 0.663 |
hERG Blockers: | 0.053 | Human Hepatotoxicity (H-HT): | 0.051 |
Drug-inuced Liver Injury (DILI): | 0.499 | AMES Toxicity: | 0.229 |
Rat Oral Acute Toxicity: | 0.029 | Maximum Recommended Daily Dose: | 0.099 |
Skin Sensitization: | 0.814 | Carcinogencity: | 0.711 |
Eye Corrosion: | 0.023 | Eye Irritation: | 0.991 |
Respiratory Toxicity: | 0.034 |